Esplanade Ventures
Venture capitalToronto · Pre-Seed–Series B · 11 people tracked
Investment thesis
Esplanade Ventures backs early-stage and high-growth digital health companies redefining healthcare delivery across North America, with a strong preference for AI-enabled software solutions that directly impact patients or healthcare professionals. The firm invests from seed to Series A rounds, with selective Series B participation and follow-on investment, and will lead, co-lead, or follow. It explicitly avoids invasive devices and biotech. Beyond capital, the team—composed of healthcare operators, founders, and investors with decades of collective experience and a network spanning North America, Europe, and Israel—provides hands-on guidance, commercial introductions, and go-to-market strategy to portfolio companies commercializing in North America.
Source: firm website, verified Aug 7, 2026.
Team · 11 people
from the firm's website & public directories
Frequently asked questions
- What stage does Esplanade Ventures invest at?
- Esplanade Ventures invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does Esplanade Ventures focus on?
- Esplanade Ventures focuses on AI & Machine Learning, Biotech, Digital Health, Enterprise Software, Healthtech, Medical Devices, SaaS.
- Where is Esplanade Ventures located?
- Esplanade Ventures is headquartered in Toronto, CA.
- Does Esplanade Ventures lead rounds?
- Yes, Esplanade Ventures leads investment rounds.
Co-investors · 6
Vensana Capital is a venture capital and growth equity investment firm focused on partnering with entrepreneurs building breakthrough medical technology innovations to transform healthcare.
Distributed Ventures is an early-stage venture firm that leads Seed and Series A investments in companies innovating across the health, insurance, and wealth risk ecosystems.
Harmonix is an early-stage venture capital firm focused on advancing human health and quality of life by backing entrepreneurs and companies in healthcare, life sciences, and deep tech.
Boehringer Ingelheim Venture Fund, established in 2010, invests in biotechnology companies developing therapeutics in immuno-oncology, regenerative medicine, and gene therapy, including platform technologies and novel vaccines. The fund targets early-stage companies addressing unmet medical needs through translational research and scientific innovation.
quadraScope invests in healthcare companies developing pharmaceuticals, diagnostics, software, equipment and devices that address the biological hallmarks of aging through biological age reversal and longevity research.
Vistara Growth is a technology-focused financing firm that partners with growth-stage companies, providing capital as both a lender and an equity partner.
Firms observed investing alongside Esplanade Ventures, from public investor directories. Shared companies are the overlap with Esplanade Ventures's recorded portfolio.
Similar investors
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, with a portfolio of companies from early stage through growth.
MDI Ventures is the corporate venture capital arm of Indonesia's Telkom Group, investing in technology startups and emphasizing measurable social and environmental impact alongside financial returns.
OCV Partners is a Los Angeles based venture capital firm backing companies with differentiated technologies in compelling markets, led by former founders leveraging company-building experience.
OUP (Osage University Partners) is a venture capital firm that backs science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.
Angel Bridge is a Japanese venture capital firm that emphasizes hands-on support as a 'supporter of entrepreneurs,' aiming to help create world-class mega ventures.